Illumina Protein Prep
Proteomic insights bridge the gap between genotype and phenotype, providing a real-time snapshot of cellular activity between healthy and disease states. The Illumina Protein Prep is an innovative aptamer-based assay leveraging the scalability of NGS technology to deliver a high-throughput, high-accuracy solution and maximize protein identification and quantification per sample. Useful in biomarker discovery, complex disease risk assessment, and precision therapeutics, NGS-based proteomics add an important piece to the cell state puzzle.
Leveraging our extensive experience with Illumina technology, SeqCenter is now offering the Illumina Protein Prep solution which uses a streamlined end-to-end workflow starting with human plasma or serum samples that are generated into sequencing-ready libraries. This proteomics assay can detect over 9000 unique protein measurements, and combining this service with our genomics and transcriptomics offerings enables secondary and tertiary analysis for combined modality studies.
To ensure quality protein abundance, it is crucial to follow the Illumina Protein Prep sample collection and general processing guidelines. Please see the “Submission Considerations” section below for more details.
Packages & Pricing
Sequencing Package | Price |
---|---|
42 Sample Block $550.00 per sample |
$23.100.00 |
85 Sample Block $500.00 per sample |
$42,500.00 |
170 Sample Block $475.00 per sample |
$80,750.00 |
425 Sample Block $450.00 per sample |
$191,250.00 |
Submission Considerations
Sample degradation begins as soon as the blood is drawn. Similar to when working with RNA, temperature has a large impact on the sample performance for this assay, meaning that the resulting data will be greatly affected by the number of freeze-thaw cycles and handling time.
To ensure high quality data, please adhere to the following guidelines and recommendations for sample collection and pre-processing, provided by Illumina.
Guidelines for Sample Collection
- Temperature considerations:
- Ideally, complete processing and freezing of plasma and serum samples within 2 hours of collection.
- If a freeze-thaw cycle must be introduced between collection and processing, store at -80°C. Thaw and process samples in batches to minimize the amount of time any given sample is not frozen.
- Up to 3 freeze-thaw cycles are permitted. (Creating multiple one-use aliquots during pre-processing is recommended.)
- Avoid extended thaw time (2 hours maximum.)
- Samples must be transported on dry ice.
- Use only unexpired collection tubes.
- Whole blood specimens for plasma samples must be collected in EDTA blood collection tubes.
- Do not freeze whole blood specimens.
- Performance is not guaranteed for samples collected using other collection tubes.
- Avoid adding anticoagulant to serum samples
- Whole blood specimens for plasma samples must be collected in EDTA blood collection tubes.
- If collecting more than one sample type, follow the collection order specified in the guidelines provided by the tube manufacturer.
- Treat all samples as if they are potentially infectious agents, including when assessing transportation regulations.
General Processing Guidelines for Both Sample Types
- Proper processing of the collected samples is critical.
- Do not chill collection tubes before processing.
- For tubes that have minimum and maximum fill lines, follow the fill guidelines indicated.
- Hemolyzed samples (colored pink to red) can prevent accurate biomarker detection. If only hemolyzed samples are available, please contact SeqCenter.
- If you will be processing more volume than required for a single use, separate it into multiple aliquots, so that each aliquot is single-use.
- Perform all steps at room temperature, but avoid leaving sample at room temperature longer than the procedure requires.
- If samples have been frozen:
- Thaw and process samples in batches to minimize the amount of time any given sample is not frozen.
- Avoid multiple freeze-thaw cycles.
- All long term storage must be at -80°C.
- Refer to the sample-type specific guidelines below.
Additional Information
We highly recommend the 2024 study by Stephan Kraemer, et al. for additional insight into aptamer-based project considerations and analyses.
Kraemer, Stephan, Daniel J. Schneider, Clare Paterson, et al. “Crossing the Halfway Point: Aptamer-Based, Highly Multiplexed Assay for the Assessment of the Proteome.” Journal of Proteome Research 23, no. 11 (2024): 4771–88. https://doi.org/10.1021/acs.jproteome.4c00411.
Contact:
91 43rd Street, Ste. 250
Pittsburgh, PA 15201
(878) 227-4915
Services:
About:
Resources: